Metabolic biomarkers and gallstone disease – a population-based study

References

• Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136:1134–1144.
   PubMed Web of Science ®Google Scholar
• Russo MW, Wei JT, Thiny MT, et al. Digestive and liver diseases statistics, 2004. Gastroenterology. 2004;126:1448–1453.
   PubMed Web of Science ®Google Scholar
• Aune D, Norat T, Vatten LJ. Body mass index, abdominal fatness and the risk of gallbladder disease. Eur J Epidemiol. 2015;30:1009–1019.
   PubMed Web of Science ®Google Scholar
• Shabanzadeh DM, Sorensen LT, Jorgensen T. Determinants for gallstone formation – a new data cohort study and a systematic review with meta-analysis. Scand J Gastroenterol. 2016;51:1239–1248.
   PubMed Web of Science ®Google Scholar
• Diehl AK. Cholelithiasis and the insulin resistance syndrome. Hepatology. 2000;31:528–530.
   PubMed Web of Science ®Google Scholar
• Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6:172–187.
   PubMed Web of Science ®Google Scholar
• WHO. Obesity: preventing and managing the global epidemic. WHO Tech Rep Ser. 2000;894:1–253.
   Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–1428.
   PubMed Web of Science ®Google Scholar
• Sutherland JP, McKinley B, Eckel RH. The metabolic syndrome and inflammation. Metab Syndr Relat Disord. 2004;2:82–104.
   PubMed Web of Science ®Google Scholar
• Kempf T, Guba-Quint A, Torgerson J, et al. Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. Eur J Endocrinol. 2012;167:671–678.
   PubMed Web of Science ®Google Scholar
• Abril-Ulloa V, Flores-Mateo G, Sola-Alberich R, et al. Ferritin levels and risk of metabolic syndrome: meta-analysis of observational studies. BMC Public Health. 2014;14:483.
   PubMed Web of Science ®Google Scholar
• Haupt TH, Kallemose T, Ladelund S, et al. Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population. Biomark Insights. 2014;9:91–100.
   PubMedGoogle Scholar
• Sakka S, Siahanidou T, Voyatzis C, et al. Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children. Clin Chem Lab Med. 2015;53:1119–1125.
   PubMed Web of Science ®Google Scholar
• Furuncuoglu Y, Tulgar S, Dogan AN, et al. How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study. Eur Rev Med Pharmacol Sci. 2016;20:1300–1306.
   PubMed Web of Science ®Google Scholar
• Rowley K, O’Dea K, Best JD. Association of albuminuria and the metabolic syndrome. Curr Diab Rep. 2003;3:80–86.
   PubMedGoogle Scholar
• Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38:320–323.
   PubMed Web of Science ®Google Scholar
• Grarup N, Rose CS, Andersson EA, et al. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes. 2007;56:3105–3111.
   PubMed Web of Science ®Google Scholar
• Stancakova A, Kuulasmaa T, Paananen J, et al. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes. 2009;58:2129–2136.
   PubMed Web of Science ®Google Scholar
• Willer CJ, Speliotes EK, Loos RJ, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009;41:25–34.
   PubMed Web of Science ®Google Scholar
• Speliotes EK, Willer CJ, Berndt SI, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42:937–948.
   PubMed Web of Science ®Google Scholar
• Meyre D, Delplanque J, Chevre JC, et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet. 2009;41:157–159.
   PubMed Web of Science ®Google Scholar
• Thorleifsson G, Walters GB, Gudbjartsson DF, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet. 2009;41:18–24.
   PubMed Web of Science ®Google Scholar
• Heard-Costa NL, Zillikens MC, Monda KL, et al. NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet. 2009;5:e1000539.
   PubMed Web of Science ®Google Scholar
• Loos RJ, Lindgren CM, Li S, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008;40:768–775.
   PubMed Web of Science ®Google Scholar
• Long JR, Liu PY, Liu YJ, et al. APOE and TGF-beta1 genes are associated with obesity phenotypes. J Med Genet. 2003;40:918–924.
   PubMed Web of Science ®Google Scholar
• Vucinic N, Djan I, Stokic E, et al. Different associations of apoE gene polymorphism with metabolic syndrome in the Vojvodina Province (Serbia). Mol Biol Rep. 2014;41:5221–5227.
   PubMed Web of Science ®Google Scholar
• Chen JY, Hsu CT, Liu JH, et al. Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan. BMC Gastroenterol. 2014;14:83.
   PubMed Web of Science ®Google Scholar
• Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology. 2000;31:299–303.
   PubMed Web of Science ®Google Scholar
• Maurer KJ, Carey MC, Fox JG. Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology. 2009;136:425–440.
   PubMed Web of Science ®Google Scholar
• Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr. 2004;80:1–2.
   PubMed Web of Science ®Google Scholar
• Jorgensen T. Prevalence of gallstones in a Danish population. Am J Epidemiol. 1987;126:912–921.
   PubMed Web of Science ®Google Scholar
• Jorgensen T. Treatment of Gallstone Patients. A Health Technology Assessment. Danish Institute for Health Technology Assessment and National Institute of Public Health; 2000.
   Google Scholar
• Shabanzadeh DM, Holmboe SA, Sorensen LT, et al. Are incident gallstones associated to sex-dependent changes with age? A cohort study. Andrology. 2017. [Epub ahead of print]. doi: 10.1111/andr.12391
   PubMed Web of Science ®Google Scholar
• Shabanzadeh DM, Jorgensen T, Linneberg A, et al. Vitamin D and gallstone disease-A population-based study. Endocrine. 2016;54:818–825.
   PubMed Web of Science ®Google Scholar
• Shabanzadeh DM, Sorensen LT, Jorgensen T. Abdominal symptoms and incident gallstones in a population unaware of gallstone status. Can J Gastroenterol Hepatol. 2016;2016:9730687.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.
   PubMed Web of Science ®Google Scholar
• Ruhl CE, Everhart JE. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol. 2013;108:952–958.
   PubMed Web of Science ®Google Scholar
• Misciagna G, Leoci C, Guerra V, et al. Epidemiology of cholelithiasis in southern Italy. Part II: risk factors. Eur J Gastroenterol Hepatol. 1996;8:585–593.
   PubMed Web of Science ®Google Scholar
• Kato I, Nomura A, Stemmermann GN, et al. Prospective study of clinical gallbladder disease and its association with obesity, physical activity, and other factors. Digest Dis Sci. 1992;37:784–790.
   PubMed Web of Science ®Google Scholar
• Boland LL, Folsom AR, Rosamond WD, et al. Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease. A Prospective Study. Ann Epidemiol. 2002;12:131–140.
   PubMed Web of Science ®Google Scholar
• Nakeeb A, Comuzzie AG, Al AH, et al. Insulin resistance causes human gallbladder dysmotility. J Gastrointest Surg. 2006;10:940–948.
   PubMed Web of Science ®Google Scholar
• Gielkens HA, van Oostayen JA, Frolich M, et al. Dose-dependent inhibition of postprandial gallbladder motility and plasma hormone secretion during acute hyperglycemia. Scand J Gastroenterol. 1998;33:1074–1079.
   PubMed Web of Science ®Google Scholar
• Ito S, Hasegawa H, Nozawa S, et al. Gallstones in patients with rheumatoid arthritis. J Rheumatol. 1999;26:1458–1466.
   PubMed Web of Science ®Google Scholar
• Tong LX, Wu S, Li T, et al. Personal history of gallstones and risk of incident psoriasis and psoriatic arthritis in U.S. women. Br J Dermatol. 2015;172:1316–1322.
   PubMed Web of Science ®Google Scholar
• Rege RV, Prystowsky JB. Inflammation and a thickened mucus layer in mice with cholesterol gallstones. J Surg Res. 1998;74:81–85.
   PubMed Web of Science ®Google Scholar
• van Erpecum KJ, Wang DQ, Moschetta A, et al. Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res. 2006;47:32–41.
   PubMed Web of Science ®Google Scholar
• Nervi F, Miquel JF, Alvarez M, et al. Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. J Hepatol. 2006;45:299–305.
   PubMed Web of Science ®Google Scholar
• Liew PL, Wang W, Lee YC, et al. Gallbladder disease among obese patients in Taiwan. Obes Surg. 2007;17:383–390.
   PubMed Web of Science ®Google Scholar
• Kim SS, Lee JG, Kim DW, et al. Insulin resistance as a risk factor for gallbladder stone formation in Korean postmenopausal women. Korean J Intern Med. 2011;26:285–293.
   PubMedGoogle Scholar
• Xue P, Niu WQ, Jiang ZY, et al. A meta-analysis of apolipoprotein E gene ε2/ε3/ε4 polymorphism for gallbladder stone disease. PLoS One. 2012;7:e45849.
   PubMed Web of Science ®Google Scholar
• Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study. Hepatology. 2013;58:2133–2141.
   PubMed Web of Science ®Google Scholar
• Portincasa P, Di Ciaula A, de Bari O, et al. Management of gallstones and its related complications. Expert Rev Gastroenterol Hepatol. 2016;10:93–112.
   PubMed Web of Science ®Google Scholar